Premium
Colchicine therapy in Behçet's syndrome—a report of five cases
Author(s) -
MUZULU S.I.,
WALTON S.,
KECZKES K.
Publication year - 1989
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/j.1365-2230.1989.tb01985.x
Subject(s) - colchicine , medicine , surgery , pediatrics
Summary Five patients with Behçet's syndrome of varying duration were treated with colchicine (500 μg b.i.d.). All improved clinically and one has remained clear for 1 year after cessation of therapy, although in one patient who had neurological symptoms, paraesthesiae have persisted throughout treatment.